AIM
CFRX

Acrospire Investment Management’s ContraFect Corporation CFRX Stock Holding History

Acrospire Investment Management’s Portfolio CFRX Stock Details CFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-13
Closed -$25K – 2525
2016
Q3 		$25K Buy
+13
New +$25.5K 0.02% 1427

Other funds holding CFRX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return

Acrospire Investment Management's CFRX Position: Q4 2016 in Review

Acrospire Investment Management sold out of ContraFect Corporation (CFRX) in Q4 2016, closing a stake of 13 shares — an estimated $25K sold.

Acrospire Investment Management first reported a position in CFRX in Q3 2016 and held it in 1 quarter. The position peaked at $25K in Q3 2016. 33 funds tracked by Wall St. Rank hold CFRX as of Q4 2016.

  • Acrospire Investment Management reported no remaining ContraFect Corporation position as of Q4 2016 after selling out during the quarter.
  • Acrospire Investment Management sold 13 ContraFect Corporation shares in Q4 2016, an estimated $25K.
  • Acrospire Investment Management first reported a position in ContraFect Corporation in Q3 2016 and held it in 1 quarter.
  • Acrospire Investment Management's ContraFect Corporation position peaked at $25K in Q3 2016.
  • 33 funds tracked by Wall St. Rank held ContraFect Corporation as of Q4 2016.

Based on Acrospire Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.